REG - Non-Standard Fin - Director/PDMR Shareholding and total voting rights

Non-Standard FinanceAnnouncement

31/07/2019 11:30

RNS Number : 3841H
Non-Standard Finance PLC
31 July 2019
 


PRESS RELEASE
 
Non-Standard Finance plc
(the 'Company' or the 'Group')
 
Director/PDMR Shareholding (notification and correction) and total voting rights
31 July 2019
 
The Group announces the issuance to Mr. Charles Gregson, Non-Executive Chairman of the Company, of 70,234 ordinary shares of £0.05 each ('Ordinary Shares') (the 'Shares').
 
In accordance with the Group's Remuneration Policy approved by shareholders on 14 May 2018, the Shares are issued to Mr. Gregson to satisfy 50% of the post-tax fees due to be paid to Mr. Gregson by the Company for the period from 1 January 2018 to 31 March 2019 (given that the purchases of Ordinary Shares purportedly purchased by the Company and transferred to Mr. Gregson for this period previously were void).
 
As a result of the issuance set out above, Mr. Gregson has a beneficial interest in 350,317 Ordinary Shares, representing 0.1% of the issued share capital of the Company.
Further to the issuance and the announcement made by the Company today regarding the reduction of the Company's capital by 5,070,234 Ordinary Shares, the Company's total issued share capital consists of 312,049,682 Ordinary Shares (with no shares held in treasury). The total number of voting rights in the Company remains unchanged at 312,049,682 (thereby meaning that the interests in the Company of the Company's shareholders also remain unchanged and no notifications will be required pursuant to the issuance under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules).
 
This announcement corrects the following 'Director / PDMR Shareholding' announcements of the Company dated: 28 June 2018 (RNS No 9264S12); 1 October 2018 (RNS No 4966C09); 21 December 2018 (RNS No 2932L11); and 29 March 2019 (RNS No 5199U12) (the 'RNSs'). The RNSs relate to Ordinary Shares purportedly purchased by the Company and transferred to Mr. Gregson. However, as the purchases by the Company were void, such transfers were not possible. As a result, the RNSs should be disregarded given that no such Ordinary Shares were transferred to Mr. Gregson.
 
For more information:

 




Non-Standard Finance plc
Peter Reynolds, Director, IR and Communications




+44 (0) 20 3869 9026




 
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:
 




1


Details of the person discharging managerial responsibilities/person closely associated




a)


Name


Charles Gregson




2


Reason for the notification




a)


Position/status


Non-Executive Chairman
 




b)


Initial notification /Amendment


Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Non-Standard Finance plc




b)


LEI


213800DVBNIJ1J2OF119




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument
Identification code


Ordinary shares of 5p each in the capital of Non-Standard Finance plc

 




GB00BRJ6JV17




b)


Nature of the transaction


Issuance of Ordinary Shares by the Company to Charles Gregson




c)


Price(s) and volume(s)


Price(s)


Volume(s)




38.95 pence


70,234




d)


Aggregated information
- Aggregated volume
- Price


Aggregated volume:  
 70,234 Ordinary Shares
38.95 pence




e)


Date of the transaction


31 July 2019




f)


Place of the transaction


London Stock Exchange (XLON)




 
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBGGDRXBXBGCB